ALLMedicine™ Lung Tumors Center
Research & Reviews 1,069 results
https://doi.org/10.1371/journal.pone.0268329
PloS One; Lugtu EJ, Ramos DB et. al.
May 14th, 2022 - Given the increasing prevalence of lung cancer worldwide, an auxiliary diagnostic method is needed alongside the microscopic examination of biopsy samples, which is dependent on the skills and experience of pathologists. Thus, this study aimed to ...
https://doi.org/10.1093/carcin/bgac041
Carcinogenesis Satoh H, Arai Y et. al.
May 14th, 2022 - The transcription factor Nrf2 plays a crucial role in the anti-oxidative stress response, protection of DNA from injury, and DNA repair mechanisms. Nrf2 activity reduces cancer initiation, but how Nrf2 affects whole-genome alterations upon carcino...
https://doi.org/10.1177/10668969221096869
International Journal of Surgical Pathology; Zhao J, Peng J et. al.
May 7th, 2022 - Alveolar soft-part sarcoma is a rare type of soft tissue malignant tumor. Although the tumor can occur in many parts of the body, primary alveolar soft-part sarcoma of the lung is extremely rare. According to previous literature, only 3 cases of p...
https://doi.org/10.1016/j.radonc.2022.04.028
Radiotherapy and Oncology : Journal of the European Socie... Matsuo Y, Hiraoka M et. al.
May 6th, 2022 - This study aimed to evaluate the safety and efficacy of dynamic tumor tracking-stereotactic body radiotherapy (DTT-SBRT) for lung tumors. Patients with cStage I primary lung cancer or metastatic lung cancer with an expected range of respiratory mo...
https://doi.org/10.2174/1871520622666220426112435
Anti-cancer Agents in Medicinal Chemistry; Rahal BA, Bardaweel SK
Apr 28th, 2022 - Lung tumors express high levels of aromatase enzyme compared to surrounding normal tissue. Inhibition of aromatase has emerged as a recent therapeutic approach for the treatment of breast cancer. However, the role of aromatase inhibition in lung c...
Drugs 8 results see all →
Clinicaltrials.gov 37 results
https://clinicaltrials.gov/ct2/show/NCT04233476
Apr 27th, 2022 - This study strictly obeyed to the result by pathological diagnoses standard. The evaluation of the efficacy of 99mTc-3PRGD2 in the diagnosis of lymph node metastasis of lung tumors is based on a multi-center, open, self-controlled clinical trial. ...
https://clinicaltrials.gov/ct2/show/NCT04200417
Apr 22nd, 2022 - This study is being done to determine if it is safe to perform lung chemoembolization and if the lung chemoembolization procedure can successfully deliver chemotherapy to lung tumors.
https://clinicaltrials.gov/ct2/show/NCT02705404
Apr 14th, 2022 - A frequent clinical dilemma in lung cancer care is the management of multifocal lung cancers. The management decision is based on determining if multiple cancers represent true independent primary cancers or related metastasis. This determination ...
https://clinicaltrials.gov/ct2/show/NCT03707925
Feb 16th, 2022 - PRIMARY OBJECTIVES: I. To assess the pathologic changes that result from bronchoscopic laser ablation of peripheral lung tumors focusing on the proportion of complete tumor ablation. SECONDARY OBJECTIVES: I. To assess the safety of this technique ...
https://clinicaltrials.gov/ct2/show/NCT03786692
Feb 10th, 2022 - While cigarette smoking remains the primary cause of most lung cancer cases, lung carcinoma in never smokers account for nearly 20 percent of cases. Never smokers with lung cancer typically present with different molecular profiles from that of sm...
News 60 results
https://www.onclive.com/view/novel-crispr-imaging-technology-reveals-genes-controlling-tumor-immunity
Mar 30th, 2022 - Mount Sinai scientists have developed a new technology allowing them to link specific genes to complex tumor characteristics at a scale and resolution not previously possible. The results could lead to new approaches for targeting anti-cancer drug...
https://www.medpagetoday.com/hematologyoncology/lungcancer/97354
Feb 24th, 2022 - Esophageal-sparing intensity-modulated radiotherapy (ES-IMRT) failed to improve esophageal quality of life, but did significantly reduce the incidence of symptomatic esophagitis, in patients with advanced non-small cell lung cancer (NSCLC), accord...
https://www.onclive.com/view/tissue-truly-is-the-issue-in-advanced-non-small-cell-lung-cancer
Oct 6th, 2021 - Jimmy Ruiz, MD Assistant Professor of Medicine, Hematology and Oncology Assistant Director of Cancer Health Equity Wake Forest Baptist Medical Center — Comprehensive Cancer Center Non-small cell lung cancer (NSCLC) is no longer...
https://www.onclive.com/view/cryoablation-may-offer-option-for-metastatic-lung-tumors
Oct 6th, 2021 - David A. Woodrum, MD, PhD The results of the first prospective multicenter trial of cryoablation in lung cancer show that this emerging treatment may be a safe, effective, and minimally invasive method of helping a specific group of patients with...
https://www.onclive.com/view/roswell-park-is-first-center-in-new-york-state-to-implement-monarch-bronchoscopy-platform
Oct 6th, 2021 - Lung specialists at Roswell Park Comprehensive Cancer Center now have a tool for visualizing and reaching lung nodules through a minimally invasive approach, enabling earlier diagnosis of cancer, smaller biopsies and broader treatment options for ...